Michael Mulkerrin
Vice President, Head of CMC
pharmaceutical sciences
adc therapeutics
Netherlands
Biography
Michael Mulkerrin is Vice President, Head of CMC (Chemistry Manufacturing and Control) of at ADC Therapeutics. Dr. Mulkerrin has extensive industry experience in biologics manufacturing. Prior to joining ADC Therapeutics, he held the position of Vice President, Process Development and Manufacturing at OncoMed Pharmaceuticals. Prior to OncoMed, Dr. Mulkerrin was the Senior Director in Process Sciences at Amgen heading Analytical Biochemistry. He also served in leadership positions in the development of therapeutic monoclonal antibody projects at Genentech and Abgenix. In 2010, Dr. Mulkerrin was elected to the USP Council of Experts, and is Chairman of the Biologics Monographs – Proteins Expert Committee. Dr. Mulkerrin has a B.S. in Biochemistry from the University of Massachusetts, Amherst, and a Ph.D. in Biochemistry from the University of Georgia, Athens.
Research Interest
